V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Globus Medical Executive Compensation (FY25)

GMED · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Keith Pfeil
Latest say-on-pay support
=
June 3, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Globus Medical

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 19, 2026Latest filing (8-K): June 4, 2026
15 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Globus Medical brief$1,500Get the executive brief
Velarion Member, one year
248 figures on this page: 237 cited to the filing that reported them, 11 calculated from figures it prints. See the citations

More on Globus Medical

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Keith Pfeil: $2,363,278 → $4,400,159 (86.2% higher)
CEO pay ratio: 51:1 → 35:1 (31.4% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Globus Medical's chief executive and what were they paid?
Total compensation for Keith Pfeil, Chief Executive Officer and President, came to $4,400,159 in fiscal 2025. Pfeil's total moved 86.2% higher from the $2,363,278 reported for fiscal 2024.
What was Globus Medical's say-on-pay result?
The say-on-pay proposal drew 98.4% support at the meeting held June 3, 2026 for fiscal 2025.
Which companies are in Globus Medical's peer group?
The disclosed peer group names Alphatec Holdings, CONMED Corporation, Dentsply Sirona, Enovis Corporation and Envista Holdings, among others.
What is Globus Medical's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 35:1, against median employee compensation of $128,616.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Scavilla
Chief Executive Officer and President
◇◇—◇◇—◇◇
David Paul
Chairman of the Board of Directors and Executive Chairman
◇◇—◇◇—◇◇
Keith Pfeil
Chief Operating Officer and Chief Financial Officer
◇◇—◇◇—◇◇
Kelly Huller
Executive Vice President, General Counsel and Corporate Secretary
◇◇—◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Scavilla
Chief Executive Officer and President
◇◇—◇◇—◇◇
David Paul
Chairman of the Board of Directors and Executive Chairman
◇——◇◇—◇◇
Keith Pfeil
Chief Operating Officer and Chief Financial Officer
◇◇—◇◇—◇◇
Kelly Huller
Executive Vice President, General Counsel and Corporate Secretary
◇◇—◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Scavilla
Chief Executive Officer and President
◇——◇◇—◇◇
David Paul
Chairman of the Board of Directors and Executive Chairman
◇——◇◇—◇◇
Keith Pfeil
Chief Operating Officer and Chief Financial Officer
◇——◇◇—◇◇
Kelly Huller
Executive Vice President, General Counsel and Corporate Secretary
◇——◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Scavilla
Former Chief Executive Officer and President
Departed during or after this year
◇——◇——◇◇
Keith Pfeil
Chief Executive Officer and President
◇◇—◇◇—◇◇
David Paul
Chairman of the Board of Directors and Executive Chairman
◇◇—◇◇—◇◇
Kelly Huller
Executive Vice President, General Counsel and Corporate Secretary
◇◇—◇◇—◇◇
Kyle Kline
Senior Vice President and Chief Financial Officer
◇◇—◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Daniel T. ScavillaOPTION◇——◇—◇◇
David C. PaulOPTION◇——◇—◇◇
Keith W. PfeilOPTION◇——◇—◇◇
Keith W. PfeilOPTION◇——◇—◇◇
Kelly G. HullerOPTION◇——◇—◇◇
Kyle R. KlineOPTION◇——◇—◇◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Keith PfeilOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Kelly HullerOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Kyle KlineOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
David PaulOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Daniel Scavilla
Former Chief Executive Officer and President · Terms as described in the company’s compensation discussion · citing a 2026 filing
Equity acceleration on change in control◇
Keith Pfeil
Chief Executive Officer and President · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance cash amount◇
Kelly Huller
Executive Vice President, General Counsel and Corporate Secretary · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance cash amount◇
Kyle Kline
Senior Vice President and Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Change-in-control trigger◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Ann D. Rhoads
◇—◇——◇◇
James R. Tobin
Lead independent director
◇—◇———◇
Daniel T. Lemaitre
◇—◇———◇
David D. Davidar
◇—◇———◇
Stephen T. Zarrilli
◇—◇———◇
John A. DeFord
◇—◇———◇
Leslie V. Norwalk
◇—◇———◇
Daniel J. Wolterman
◇—◇———◇
Robert A. Douglas
◇—◇———◇
Keith W. Pfeil and David C. Paul served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alphatec Holdings ATEC
  • CONMED Corporation CNMD
  • Dentsply Sirona XRAY
  • Enovis Corporation ENOV
  • Envista Holdings NVST
  • Glaukos Corporation GKOS
  • Insulet Corporation PODD
  • Integer Holdings ITGR
  • Integra LifeSciences IART
  • LivaNova PLC LIVN
  • Merit Medical Systems MMSI
  • Penumbra Inc. PEN
  • QuidelOrtho Corporation QDEL
  • Teleflex Incorporated TFX
  • The Cooper Companies COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 3, 2026=◇◇◇
2024June 4, 2025=◇◇◇
2023June 5, 2024=◇◇◇
2022June 7, 2023=◇◇◇
2021June 2, 2022=◇◇◇
2020June 3, 2021=◇◇◇
2019June 3, 2020=◇◇◇
2018June 5, 2019=◇◇◇
2017June 6, 2018=◇◇◇
2016June 7, 2017=◇◇◇
2015June 14, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Keith Pfeil (Chief Executive Officer and President), FY2025 total compensation $4,400,159 (base salary $479,467) [exec_comp, SEC accession 0001628280-26-027196, filed 2026-04-24]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when Globus Medical files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Globus Medical disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Globus Medical sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Globus Medical's disclosed peer group is defensible, who names Globus Medical back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
248 figures on this page: 237 cited to the filing that reported them, 11 calculated from figures it prints.
237 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001628280-26-040784
  2. 0001628280-26-027196
    2025 Outstanding Equity Awards at Fiscal Year-End · Compensation Discussion and Analysis · Director Compensation · Grants of Plan-Based Awards · and 2 more sections
  3. 0001562762-25-000158
  4. 0001562762-25-000092
  5. 0001562762-24-000163
  6. 0001562762-24-000102
    Summary Compensation Table
  7. 0001562762-23-000269
  8. 0001562762-23-000185
    Summary Compensation Table
  9. 0001562762-22-000267
  10. 0001562762-21-000242
  11. 0001237831-20-000041
  12. 0001237831-19-000030
  13. 0001237831-18-000027
  14. 0001237831-17-000027
  15. 0001237831-16-000090
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Globus Medical executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/GMED (accessed 2026).
Short form: data: Velarion

The paid brief for Globus Medical

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Globus Medical and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Globus Medical discloses

The companies named in GMED's own disclosed peer group.

Alphatec HoldingsCONMED CorporationDentsply SironaEnovis CorporationEnvista HoldingsGlaukos CorporationInsulet CorporationInteger HoldingsIntegra LifeSciencesLivaNova PLCMerit Medical SystemsPenumbra Inc.QuidelOrtho CorporationTeleflex IncorporatedThe Cooper Companies

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy